Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins.
The classification of demineralized bone matrix (DBM) includes gel, putty, putty with chips, and the proportion of Putty in 2017 is about 46%, and the proportion is in decreasing trend from 2013 to 2017.
Demineralized bone matrix (DBM) is widely used in dental surgery, spine surgery, trauma surgery. The most proportion of demineralized bone matrix (DBM) is for spine surgery, and the proportion in 2017 is about 78%.

According to this study, over the next five years the Demineralized Bone Matrix (DBM) market will register a 4.2% CAGR in terms of revenue, the global market size will reach US$ 860 million by 2024, from US$ 700 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Demineralized Bone Matrix (DBM) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Demineralized Bone Matrix (DBM) market by product type, application, key manufacturers and key regions and countries.

This study considers the Demineralized Bone Matrix (DBM) value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Gel
Putty
Putty with Chips
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Dental
Spine Surgery
Trauma Surgery

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic
J &J (DePuy Synthes)
Zimmer Biomet
Stryker
SeaSpine
Straumann
Xtant Medical
Wright Medical Group
RTI Surgical
Hans Biomed
Arthrex

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Demineralized Bone Matrix (DBM) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Demineralized Bone Matrix (DBM) market by identifying its various subsegments.
Focuses on the key global Demineralized Bone Matrix (DBM) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Demineralized Bone Matrix (DBM) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Demineralized Bone Matrix (DBM) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.